MedTrace Logo

Will Erectile Dysfunction Increase the Risk of Prostate Cancer

NCT03009123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21558

Last updated 2017-05-09

No results posted yet for this study

Summary

The rationale for investigating the hypothesis that there is an association between erectile dysfunction (ED) and the subsequent development of prostate cancer is based on three assumptions: 1) baseline ED is common in most if not all of the cross-sectional studies in men with prostate cancer; 2) the development of ED and prostate cancer may have certain shared common risk factors; and 3) the use of testosterone for the treatment of ED has been suspected to be associated with prostate cancer development. Controversy exists over whether men with ED have an increased risk of subsequent prostate cancer. Few studies have evaluated the risk of developing prostate cancer for men with ED. The investigators, therefore, conducted a population-based longitudinal study with eight years' follow-up to examine this association and to evaluate the magnitude of the risk.

Conditions

Interventions

OTHER

Erectile dysfunction

Patients with ED are considered belonging to the exposure group.

Sponsors & Collaborators

  • Asia University

    collaborator OTHER

  • National Central University, Taiwan

    collaborator OTHER

  • Kuang Tien General Hospital

    lead OTHER

Principal Investigators

  • Victor C Kok, MD, PhD · Disease Informatics Research Unit, Asia University Taiwan

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-03-15
Completion
2017-05-06

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03009123 on ClinicalTrials.gov